Interaction of leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1764-1774

  Vieira, Monica L ^a,b   Alvarez Flores, P ^a   Kirchgatter, Karin ^b   Romero, Eliete C ^c   Alves, Ivy J ^a   De Morais, Zenaide M ^b   Vasconcellos, Silvio A ^b   Chudzinski Tavassi, Ana M ^a,d   Nascimento, Ana L T O ^a,b  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PROTEINASE;

ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ZYMOGRAPHY;

ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIN; HOST-PATHOGEN INTERACTIONS; HUMANS; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PROTEOLYSIS; UMBILICAL VEINS;

EID: 84877799544     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00020-13     Document Type: Article

References (41)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz J.. Peru-United States Leptospirosis Consortium. 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3:757-771.
2. Faine S, Adler B, Bolin C, Perolat P. 1999. Leptospira and leptospirosis, 2nd ed, p 259. MediSci, Melbourne, Australia.
3. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP. 2003. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422: 888-893.
4. Nascimento AL, Verjovski-Almeida S, Van Sluys MA, Monteiro- Vitorello CB, Camargo LE, Digiampietri LA, Harstkeerl RA, Ho PL, Marques MV, Oliveira MC, Setubal JC, Haake DA, Martins EA. 2004. Genome features of Leptospira interrogans serovar Copenhageni. Braz. J. Med. Biol. Res. 37:459-477.
5. Bulach DM, Zuerner RL, Wilson P, Seemann T, McGrath A, Cullen PA, Davis J, Johnson M, Kuczek E, Alt DP, Peterson-Burch B, Coppel RL, Rood JI, Davies JK, Adler B. 2006. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc. Natl. Acad. Sci. U. S. A. 103:14560 -14565.
6. Picardeau M, Bulach DM, Bouchier C, Zuerner RL, Zidane N, Wilson PJ, Creno S, Kuczek ES, Bommezzadri S, Davis JC, McGrath A, Johnson MJ, Boursaux-Eude C, Seemann T, Rouy Z, Coppel RL, Rood JI, Lajus A, Davies JK, Medigue C, Adler B. 2008. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 3:e1607. doi:10 .1371/journal.pone.0001607.
7. Adler B, Lo M, Seemann T, Murray GL. 2011. Pathogenesis of leptospirosis: the influence of genomics. Vet. Microbiol. 153:73- 81.
8. Cinco M. 2010. New insights into the pathogenicity of leptospires: evasion of host defences. New Microbiol. 33:283-292.
9. Evangelista KV, Coburn J. 2010. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 5:1413-1425.
10. Barocchi MA, Ko AI, Reis MG, McDonald KL, Riley LW. 2002. Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect. Immun. 70:6926- 6932.
11. Lahteenmaki K, Kuusela P, Korhonen TK. 2001. Bacterial plasminogen activators and receptors. FEMS Microbiol. Rev. 25:531-552.
12. Coleman JL, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL. 1995. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect. Immun. 63:2478 -2484.
13. Vieira ML, Vasconcellos SA, Goncales AP, de Morais ZM, Nascimento AL. 2009. Plasminogen acquisition and activation at the surface of Leptospira species lead to fibronectin degradation. Infect. Immun. 77:4092- 4101.
14. Vieira ML, Atzingen MV, Oliveira TR, Oliveira R, Andrade DM, Vasconcellos SA, Nascimento AL. 2010. In vitro identification of novel plasminogen- binding receptors of the pathogen Leptospira interrogans. PLoS One 5:e11259. doi:10.1371/journal.pone.0011259.
15. Oliveira R, de Morais ZM, Goncales AP, Romero EC, Vasconcellos SA, Nascimento AL. 2011. Characterization of novel OmpA-like protein of Leptospira interrogans that binds extracellular matrix molecules and plasminogen. PLoS One 6:e21962. doi:10.1371/journal.pone.0021962.
16. Mendes RS, Von Atzingen M, de Morais ZM, Goncales AP, Serrano SM, Asega AF, Romero EC, Vasconcellos SA, Nascimento AL. 2011. The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection. Infect. Immun. 79: 4657-4667.
17. Domingos RF, Vieira ML, Romero EC, Goncales AP, Morais ZM, Vasconcellos SA, Nascimento AL. 2012. Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions. BMC Microbiol. 12:50. doi:10.1186/1471-2180-12-50.
18. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52:2745-2756.
19. Hoshi H, McKeehan WL. 1984. Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture. Proc. Natl. Acad. Sci. U. S. A. 81:6413- 6417.
20. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. 1979. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc. Natl. Acad. Sci. U. S. A. 76:5674 -5678.
21. Vieira ML, Pimenta DC, de Morais ZM, Vasconcellos SA, Nascimento ALTO. 2009. Proteome analysis of Leptospira interrogans virulent strain. Open Microbiol. J. 3:69 -74.
22. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Methods 25: 402-408.
23. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-444.
24. Gebbia JA, Coleman JL, Benach JL. 2001. Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect. Immun. 69:456-462.
25. Plank R, Dean D. 2000. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect. 2:1265-1276.
26. Verma A, Brissette CA, Bowman AA, Shah ST, Zipfel PF, Stevenson B. 2010. Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen. Infect. Immun. 78:2053-2059.
27. Vieira ML, de Morais ZM, Vasconcellos SA, Romero EC, Nascimento AL. 2011. In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb. Pathog. 51: 360-365.
28. Madathiparambil MG, Cattavarayane S, Manickam GD, Singh K, Perumana SR, Sehgal SC. 2011. A zymography analysis of proteinase activity present in Leptospira. Curr. Microbiol. 62:917-922.
29. Madathiparambil MG, Cattavarayane S, Perumana SR, Manickam GD, Sehgal SC. 2011. Presence of 46 kDa gelatinase on the outer membrane of Leptospira. Curr. Microbiol. 62:1478 -1482.
30. Zuerner RL. 1 October2005. Laboratory maintenance of pathogenic Leptospira. Curr. Protoc. Microbiol. Chapter 12:12E.1.1-12E1.13. doi:10 .1002/9780471729259.mc12e01s00.
31. Collen D, Tytgat G, Claeys H, Verstraete M, Wallen P. 1972. Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. J. Clin. Invest. 51:1310 -1318.
32. Siemens N, Patenge N, Otto J, Fiedler T, Kreikemeyer B. 2011. Streptococcus pyogenes M49 plasminogen/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing. J. Biol. Chem. 286:21612-21622.
33. Stie J, Bruni G, Fox D. 2009. Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasion. PLoS One 4:e5780. doi:10.1371/journal.pone.0005780.
34. Knipe L, Meli A, Hewlett L, Bierings R, Dempster J, Skehel P, Hannah MJ, Carter T. 2010. A revised model for the secretion of tPA and cytokines from cultured endothelial cells. Blood 116:2183-2191.
35. Oliver JJ, Webb DJ, Newby DE. 2005. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler. Thromb. Vasc. Biol. 25:2470 -2479.
36. Huang YH, Lei HY, Liu HS, Lin YS, Chen SH, Liu CC, Yeh TM. 2003. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J. Med. Virol. 70:610-616.
37. Vanlaere I, Libert C. 2009. Matrix metalloproteinases as drug targets in infections caused by Gram-negative bacteria and in septic shock. Clin. Microbiol. Rev. 22:224 -239.
38. Elkington PT, O'Kane CM, Friedland JS. 2005. The paradox of matrix metalloproteinases in infectious disease. Clin. Exp. Immunol. 142:12-20.
39. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S. 1981. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41:4629-4636.
40. Liotta LA, Goldfarb RH, Terranova VP. 1981. Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin. Thromb. Res. 21:663- 673.
41. Lahteenmaki K, Edelman S, Korhonen TK. 2005. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 13: 79-85.